Hiromasa Kuroda

Hiromasa Kuroda

Auto-generated profile, based on publicly available information

Hiromasa Kuroda

Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in Gynecologic Oncology
Verified
Journal Article
Closed access
SMSeiji Mabuchi
Seiji Mabuchi
HKHiromasa Kuroda
Hiromasa Kuroda
RTRyoko Takahashi
Ryoko Takahashi
TSTomoyuki Sasano
Tomoyuki Sasano

1 January 2017 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
EYEriko Yokoi
Eriko Yokoi
SMSeiji Mabuchi
Seiji Mabuchi
RTRyoko Takahashi
Ryoko Takahashi
YMYuri Matsumoto
Yuri Matsumoto
HKHiromasa Kuroda
Hiromasa Kuroda
TKTadashi Kimura
Tadashi Kimura
Yokoi E, et al. J Gynecol Oncol. 2016 Aug;28:e19. https://doi.org/10.3802/jgo.2017.28.e19

14 August 2018 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
TSTomoyuki Sasano
Tomoyuki Sasano
SMSeiji Mabuchi
Seiji Mabuchi
KKKatsumi Kozasa
Katsumi Kozasa
HKHiromasa Kuroda
Hiromasa Kuroda
MKMahiru Kawano
Mahiru Kawano
TKTadashi Kimura
Tadashi Kimura
Purpose: The aim of this study was to investigate the metastatic potential of uterine cervical and endometrial cancer displaying tumor-related leukocytosis (TRL). Experimental Design: Clinical data on uterine cervical (N = 732) and endometrial cancer (N = 900) were collected, and the metastatic potential of TRL-positive cancer was evaluated in univariate and multivariate analyses. Tumor and blood samples obtained from patients with cervical cancer, cervical cancer cell lines, and a mouse model of cervical cancer were used to examine the mechanisms underlying the highly metastatic nature of TRL-positive cancer, focusing on tumor-derived G-CSF and the myeloid-derived suppressor cell (MDSC)-mediated premetastatic niche. Results: Pretreatment TRL was significantly associated with visceral organ metastasis in patients with uterine cervical or endometrial cancer. The patients with TRL-positive cervical cancer displayed upregulated tumor G-CSF expression, elevated G-CSF levels, and increased MDSC frequencies in the peripheral blood compared with the TRL-negative patients. In vitro and in vivo investigations revealed that MDSCs produced in response to tumor-derived G-CSF are involved in premetastatic niche formation, which promotes visceral organ metastasis of TRL-positive cancer. The depletion of MDSCs attenuated this premetastatic niche formation and effectively inhibited the visceral organ metastasis of TRL-positive cancer. Conclusions: Uterine cervical/endometrial cancer displaying TRL is a distinct clinical entity with high metastatic potential. Tumor-derived G-CSF and the MDSC-mediated premetastatic niche are responsible for the highly metastatic nature of this type of cancer. MDSC-targeting therapy might represent a potential strategy for combating metastasis derived from TRL-positive uterine cancer. Clin Cancer Res; 24(16); 4018–29. ©2018 AACR.

1 June 2017 in Gynecologic Oncology
Verified
Journal Article
Closed access
PDF file
YMYuri Matsumoto
Yuri Matsumoto
SMSeiji Mabuchi
Seiji Mabuchi
KKKatsumi Kozasa
Katsumi Kozasa
HKHiromasa Kuroda
Hiromasa Kuroda
TSTomoyuki Sasano
Tomoyuki Sasano
TKTadashi Kimura
Tadashi Kimura

1 April 2015 in Gynecologic Oncology
Verified
Journal Article
Closed access
RTRyoko Takahashi
Ryoko Takahashi
SMSeiji Mabuchi
Seiji Mabuchi
MKMahiru Kawano
Mahiru Kawano
TSTomoyuki Sasano
Tomoyuki Sasano
YMYuri Matsumoto
Yuri Matsumoto
TKTadashi Kimura
Tadashi Kimura

13 March 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
SMSeiji Mabuchi
Seiji Mabuchi
NKNaoko Komura
Naoko Komura
TSTomoyuki Sasano
Tomoyuki Sasano
KSKotaro Shimura
Kotaro Shimura
EYEriko Yokoi
Eriko Yokoi
TKTadashi Kimura
Tadashi Kimura
The accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG-PET/CT) can be influenced by the increased glycolytic activity of inflammatory lesions. Here, using clinical data obtained from gynecological cancer patients, tumor samples and animal models, we investigate the impact of pretreatment tumor-related leukocytosis (TRL) on the diagnostic performance of 18F-FDG-PET/CT in detecting pelvic and paraaortic lymph node metastasis. We demonstrate that pretreatment TRL misleads 18F-FDG-PET/CT during lymph node staging in gynecological malignancies. In the mechanistic investigations, we show that the false-positive 18F-FDG-PET/CT result for detecting nodal metastasis can be reproduced in animal models of TRL-positive cancer bearing G-CSF expressing cervical cancer cells. We also show that increased 18F-FDG uptake in non-metastatic nodes can be explained by the MDSC-mediated premetastatic niche formation in which proinflammatory factors, such as S100A8 or S100A9, are abundantly expressed. Together, our results suggest that the MDSC-mediated premetastatic niche created in the lymph node of TRL-positive patients misleads 18F-FDG-PET/CT for detecting nodal metastasis.